| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chairman and CEO | CEO and Chairman +2 more
5 companies
Surendra K Ajjarapu is Director at WGRX, with reported holdings spanning 5 companies. Surendra K Ajjarapu's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.5M at current prices.
Surendra K Ajjarapu's largest disclosed position is in TVGN as CEO and Chairman, worth about $5.9M.
Surendra K Ajjarapu has 16 Form 4 filings on record from December 2016 to June 2026, across 5 companies: Director at DataMEDS AI (MEDS), 2026; Director at Wellgistics Health (WGRX), 2025–2026; Chairman and CEO at Scienture (SCNX), 2016–2024, and 2 more.
The 36 reported transactions were 15 other transactions, 10 stock awards, 5 option or other derivative awards and 2 open-market purchases, plus smaller numbers of other types.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.